Form 8-K - Current report:
SEC Accession No. 0001193125-26-006994
Filing Date
2026-01-08
Accepted
2026-01-08 07:07:49
Documents
14
Period of Report
2026-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d92848d8k.htm   iXBRL 8-K 41147
2 EX-99.1 d92848dex991.htm EX-99.1 26952
6 GRAPHIC g92848g0108042339595.jpg GRAPHIC 4496
  Complete submission text file 0001193125-26-006994.txt   203657

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA clym-20260108.xsd EX-101.SCH 2838
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE clym-20260108_lab.xml EX-101.LAB 18734
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clym-20260108_pre.xml EX-101.PRE 11698
16 EXTRACTED XBRL INSTANCE DOCUMENT d92848d8k_htm.xml XML 3766
Mailing Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481
Business Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481 1-866-857-2596
Climb Bio, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 26517342
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)